- About
- Hard Capsules
-
Dosage Form Solutions
- What we do
- Drug Design and Technologies
- Drug Development and Scale-Up
- Manufacturing of Finished Dosage Forms
Dosage Form Solutions
Innovative drug-delivery technologies, specialized manufacturing, and a collaborative approach to address clients’ most pressing product development challenges.
- Knowledge Center
- News & Events
Capsugel Now a Standalone Business
Aug, 01, 2011
Pfizer Inc. announced today that it has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”), following the receipt of required regulatory clearances, including in the U.S. and the European Union. Under the terms of the previously announced agreement, KKR acquired the Capsugel business for $2.375 billion in cash.